Apollo Hospitals' shareholders and creditors have overwhelmingly approved a major restructuring scheme involving demerger and amalgamation. The plan to rename the resultant company 'Apollo Healthco Limited' now awaits final NCLT approval.
Apollo Hospitals' Major Restructuring Gets Shareholder and Creditor Nod
Apollo Hospitals Enterprise Ltd has achieved a crucial milestone in its corporate restructuring, with its equity shareholders, secured creditors, and unsecured creditors voting in favour of a composite scheme of arrangement. The meetings, convened by the National Company Law Tribunal (NCLT), saw overwhelming support for the proposed changes.
Reader Takeaway: Strong stakeholder support for restructuring; final NCLT approval pending.
What Just Happened
On June 24, 2026, NCLT-convened meetings confirmed that the composite scheme of arrangement has been approved by the requisite majority across all voting categories. For equity shareholders, 11,00,90,750 out of 12,17,26,828 polled votes were in favour, representing approximately 90.44% support. Secured creditors' approval was unanimous among those who voted on ₹1,737.94 crore of debt, with ₹367.61 crore voting in favour. Unsecured creditors also unanimously approved, with ₹181.18 crore out of ₹349.99 crore voted in favour.
Why This Matters
This approval signifies strong backing from stakeholders for Apollo Hospitals' plan to demerge its 'Identified Business Undertaking' into a new entity, which will be renamed 'Apollo Healthco Limited'. This move aims to consolidate specific business units and streamline operations, potentially unlocking value for shareholders. It clears a significant procedural hurdle in the complex process of corporate restructuring.
The Backstory
The scheme involves the demerger of a business undertaking into a resultant company (Apollo Healthtech Limited, to be renamed Apollo Healthco Limited) and the amalgamation of other entities into this resultant company. An 'upside share agreement' dated June 30, 2025, between Rasmeli Limited and Ms. Shobana Kamineni, related to management incentives, was also noted as part of the scheme.
What Changes Now
The company is now progressing towards the final stages of the restructuring. The focus will be on securing the final sanction from the Hon'ble National Company Law Tribunal, Chennai Bench, and any other necessary regulatory approvals. The board of the resultant company will also be reconstituted as per the scheme's provisions.
Risks to Watch
Despite the favourable voting outcomes, the scheme is still conditional on final approval from the NCLT and other relevant regulatory authorities. Any delays or adverse decisions from these bodies could impact the implementation timeline and the overall effectiveness of the restructuring.
Context Metrics (Time-bound)
- Voting Date: June 24, 2026
- Record Date for Debt: December 31, 2025
- Upside Share Agreement Date: June 30, 2025
- Total Equity Votes Polled: 12,17,26,828
- Equity Votes in Favour: 11,00,90,750
- Total Secured Debt Voted: ₹1,737.94 crore
- Total Unsecured Debt Voted: ₹349.99 crore
What to Track Next
Investors should closely monitor announcements regarding the NCLT's final order. The subsequent steps for the demerger and amalgamation, including the official rebranding to Apollo Healthco Limited, will be key developments to track.